JPH0649065B2 - Skin damage protection material - Google Patents
Skin damage protection materialInfo
- Publication number
- JPH0649065B2 JPH0649065B2 JP61124759A JP12475986A JPH0649065B2 JP H0649065 B2 JPH0649065 B2 JP H0649065B2 JP 61124759 A JP61124759 A JP 61124759A JP 12475986 A JP12475986 A JP 12475986A JP H0649065 B2 JPH0649065 B2 JP H0649065B2
- Authority
- JP
- Japan
- Prior art keywords
- support
- skin
- present
- notch
- gel composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000463 material Substances 0.000 title claims description 22
- 230000037380 skin damage Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 claims description 17
- 150000005846 sugar alcohols Polymers 0.000 claims description 11
- 229920001477 hydrophilic polymer Polymers 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 6
- 239000000499 gel Substances 0.000 description 14
- 230000001681 protective effect Effects 0.000 description 14
- 206010052428 Wound Diseases 0.000 description 13
- 208000027418 Wounds and injury Diseases 0.000 description 12
- 210000000416 exudates and transudate Anatomy 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 208000010201 Exanthema Diseases 0.000 description 6
- 239000002390 adhesive tape Substances 0.000 description 6
- 201000005884 exanthem Diseases 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 206010037844 rash Diseases 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000004745 nonwoven fabric Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000003223 protective agent Substances 0.000 description 2
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- CNIIGCLFLJGOGP-UHFFFAOYSA-N 2-(1-naphthalenylmethyl)-4,5-dihydro-1H-imidazole Chemical compound C=1C=CC2=CC=CC=C2C=1CC1=NCCN1 CNIIGCLFLJGOGP-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- NEZONWMXZKDMKF-JTQLQIEISA-N Alkannin Chemical compound C1=CC(O)=C2C(=O)C([C@@H](O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-JTQLQIEISA-N 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 101100008046 Caenorhabditis elegans cut-2 gene Proteins 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 241001071917 Lithospermum Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 206010053692 Wound complication Diseases 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- UNNKKUDWEASWDN-UHFFFAOYSA-N alkannin Natural products CC(=CCC(O)c1cc(O)c2C(=O)C=CC(=O)c2c1O)C UNNKKUDWEASWDN-UHFFFAOYSA-N 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960005274 benzocaine Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 1
- IVHBBMHQKZBJEU-UHFFFAOYSA-N cinchocaine hydrochloride Chemical compound [Cl-].C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCC[NH+](CC)CC)=C21 IVHBBMHQKZBJEU-UHFFFAOYSA-N 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 229940045574 dibucaine hydrochloride Drugs 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明は、創傷、火傷、湿疹、凍傷、日焼け等の皮膚の
損傷面を保護する皮膚損傷面保護材に関し、更に詳述す
ると、密着性、安全性、透湿性、柔軟性に優れ、かぶれ
等を生じさせることなく皮膚損傷面を良好に保護し得る
皮膚損傷面保護材に関する。TECHNICAL FIELD The present invention relates to a skin-damaged surface protective material for protecting a damaged surface of the skin such as wounds, burns, eczema, frostbite, and sunburns. The present invention relates to a skin-damaged surface protective material which is excellent in safety, moisture permeability and flexibility, and can protect a skin-damaged surface satisfactorily without causing a rash or the like.
〔従来の技術〕 従来、創傷面、火傷面等の皮膚損傷面を保護する場合、 (1)損傷面にガーゼや脱脂綿を当ててその上から粘着テ
ープで止める (2)損傷面に吸収パットと粘着絆とを組み合わせたいわ
ゆる救急医療用粘着パットを貼る (3)水を含ませた布を損傷面に当てがうといった方法が
採用されている。しかしながら、(1)の方法は、傷の修
復に伴い、ガーゼや脱脂綿の交換処理の際これらが傷口
にからんで傷口を再びこわしたり、ガーゼや脱脂綿を粘
着テープを用いて押さえるため、その粘着テープの粘着
剤によるかぶれが生ずる等の問題点を有し、(2)の方法
は、救急医療用粘着パッドはパッドよりも粘着テープが
広いので貼付した部分がむれたり、粘着テープによるか
ぶれが生ずる等の問題点を有し、(3)の方法は、上から
衣服を着用することができない等の問題点を有してお
り、このため従来よりこれらの問題点を改善することが
望まれている。(Conventional technology) Conventionally, when protecting a skin-damaged surface such as a wound surface or a burn surface, (1) apply gauze or absorbent cotton to the damaged surface and stop it with adhesive tape (2) use an absorbent pad on the damaged surface. A so-called emergency medical adhesive pad that is combined with an adhesive bond is applied. (3) A method of applying a cloth containing water to the damaged surface is adopted. However, in the method (1), when the gauze or absorbent cotton is exchanged with the repair of the wound, these may get entangled in the wound and break the wound again, or the gauze or absorbent cotton is pressed with an adhesive tape. There is a problem such as rash due to the adhesive of (1), the method of (2), the adhesive tape for emergency medical care has a wider adhesive tape than the pad, so the part stuck is peeled, rash due to adhesive tape etc. The method (3) has a problem that clothes cannot be worn from above, and therefore it is desired to improve these problems from the past. .
本発明の目的は、従来使用されている皮膚損傷面保護材
の上述のような問題点を解決し、治療効果が高く、痛み
の少ない、安全なものを得ることにある。An object of the present invention is to solve the above-mentioned problems of the conventionally used skin-damaged surface protecting material, and to obtain a safe material having a high therapeutic effect and less pain.
上述の目的を達成するため、本発明によれば、多価アル
コール中でコロイド状懸濁液を形成する親水性高分子及
び多価アルコールを含有するゲル組成物を支持体に塗布
し、この支持体にはその厚さ全体には達しない切り込み
を設け、この切り込みは引き裂くことにより支持体外部
に開孔し得るようになっている。To achieve the above object, according to the present invention, a gel composition containing a hydrophilic polymer forming a colloidal suspension in a polyhydric alcohol and the polyhydric alcohol is applied to a support, The body is provided with a notch that does not reach its entire thickness, which notch can be torn to open the outside of the support.
多価アルコール中でコロイド状懸濁液を形成する親水性
高分子としては、例えばアルギン酸、タラカントガム、
アラビアガム、カラヤガム、ゼラチン、ポリビニルピロ
リドン、ポリビニルアルコール、ポリアクリル酸又はそ
の塩、ポリエチレンオキサイド、カルボキシメチルセル
ロース等が好適に使用し得る。Hydrophilic polymers that form colloidal suspensions in polyhydric alcohols include, for example, alginic acid, taracant gum,
Gum arabic, karaya gum, gelatin, polyvinylpyrrolidone, polyvinyl alcohol, polyacrylic acid or a salt thereof, polyethylene oxide, carboxymethyl cellulose and the like can be preferably used.
多価アルコールとしては通常用いられるすべてのものを
使用することができ、例えばグリセリン、ソルビトー
ル、プロピレングリコール、ポリエチレングリコール、
ジ又はトリエチレングリコール、1,3−プロパンジオ
ール、1,4−ブタンジオール等の1種又は2種以上を
使用することができる。As the polyhydric alcohol, it is possible to use all those usually used, for example, glycerin, sorbitol, propylene glycol, polyethylene glycol,
One or more of di- or triethylene glycol, 1,3-propanediol, 1,4-butanediol and the like can be used.
多価アルコール中でコロイド状懸濁液を形成する親水性
高分子の配合量はゲル組成物全体の0.5〜50%(重量
%、以下同じ)、特に10〜40%が好ましく、多価ア
ルコールの配合量はゲル組成物全体の0.5〜80%とす
るのが好ましく、これらの範囲を外れるとゲル組成物の
保湿性、密着性、柔軟性のいずれかの性質が低下する。The amount of the hydrophilic polymer that forms a colloidal suspension in the polyhydric alcohol is preferably 0.5 to 50% (weight%, the same applies below), particularly 10 to 40% of the total gel composition. The blending amount is preferably 0.5 to 80% of the whole gel composition, and if it is out of these ranges, any one of the moisture retaining property, the adhesive property and the flexibility of the gel composition deteriorates.
支持体としてはいずれのものも使用することができる
が、特に不織布またはガーゼを用いることが好ましい。Any material can be used as the support, but it is particularly preferable to use a non-woven fabric or gauze.
本発明の実施においては、上記多価アルコール中でコロ
イド状懸濁液を形成する親水性高分子、多価アルコール
をそのまま混合するか、あるいは水と混合してゲル組成
物を調製し、これを厚さ全体に達しない切り込みを有す
る支持体に塗布することにより損傷面保護材を得るもの
であるが、この場合水の量はゲル組成物全体の20〜8
5%とすることができ、このゲル組成物は上述した成分
を使用することにより、水を多量に配合しても良好な保
形性を有しているものである。また、このような水を含
むゲル組成物を加熱乾燥するなどして水分を除いたも
の、あるいは水分量を少なくしたものも本発明保護剤と
して好適に使用することができる。In the practice of the present invention, a hydrophilic polymer that forms a colloidal suspension in the above polyhydric alcohol, the polyhydric alcohol are mixed as they are, or they are mixed with water to prepare a gel composition. A damaged surface protective material is obtained by applying it to a support having a notch that does not reach the entire thickness. In this case, the amount of water is 20 to 8 of the total gel composition.
The gel composition has a good shape-retaining property even when a large amount of water is added, by using the above-mentioned components. In addition, a gel composition containing such water, which has been dried by heating to remove water, or a water-reduced gel composition, can be suitably used as the protective agent of the present invention.
また、上記ゲル組成物には、更に塩化ベンゼトニウム、
塩化ベンザルコニウム、グルコン酸クロルヘキシジン、
セチリピリジニウムクロライド、ビオゾール等の殺菌
剤、マレイン酸クロルフェニラミン、塩酸ジフェンヒド
ラミン等の抗ヒスタミン剤、塩酸ジブカイン、リドカイ
ン、ベンゾカイン、塩酸ピロカイン等の局所麻酔剤、塩
酸エビレナミン、塩酸フェニレリン、塩酸ナフアゾリン
等の止血剤、シコニン、イクタモール、アロエ、ヒノキ
チオール、グリチルリチン酸、尿素等の創傷治療効果の
ある成分といった有効成分、酸化亜鉛、ベントナイト、
モンモリロナイト、酸化チタン等の無機粉体といった賦
型剤等を配合することができる。Further, the gel composition further comprises benzethonium chloride,
Benzalkonium chloride, chlorhexidine gluconate,
Fungicides such as cetiripyridinium chloride and biozole, antihistamines such as chlorpheniramine maleate and diphenhydramine hydrochloride, local anesthetics such as dibucaine hydrochloride, lidocaine, benzocaine and pirocaine hydrochloride, hemostats such as ebilemin hydrochloride, phenyleline hydrochloride and nafazoline hydrochloride. , Shikonin, ictamol, aloe, hinokitiol, glycyrrhizic acid, active ingredients such as ingredients having a wound healing effect such as urea, zinc oxide, bentonite,
A shaping agent such as an inorganic powder such as montmorillonite or titanium oxide may be added.
本発明によるゲル組成物を支持体に展延、塗布する場
合、厚さ0.1〜5mmに展延、塗布することが好ましい。When the gel composition according to the present invention is spread and applied on a support, it is preferable to spread and apply it to a thickness of 0.1 to 5 mm.
創傷によっては多量の滲出液が出るものがあるが、この
滲出液が保護剤により閉じ込められそこに貯留すると、
腐敗して化膿するおそれがある。本発明に用いられる支
持体はその厚さ全体には達しない切り込みを予め入れて
あるから、その切り込みを適宜開孔して使用することに
より、創傷面から出てくる多量の滲出液は支持体を通過
して保護材外部に排出され、創面と保護材の中に滲出液
が貯留しないようにすることができる。Depending on the wound, a large amount of exudate may come out, but if this exudate is trapped by the protective agent and accumulated there,
May decompose and purify. Since the support used in the present invention is preliminarily provided with a notch that does not reach the entire thickness, a large amount of exudate emerging from the wound surface can be used by appropriately opening the notch. It is possible to prevent the exudate from being stored in the wound surface and the protective material after being discharged to the outside of the protective material after passing through.
次に本発明の実施例について説明する。 Next, examples of the present invention will be described.
実施例1 上記組成のゲル組成物を不織布上に厚さ1.0mmとなるよ
うに均一に展延、塗布し、これを自然乾燥後蒸気滅菌し
て、本発明の皮膚損傷面保護材、特にデルマトームによ
る採皮創の痛み軽減用として最適なものを得ることがで
きた。その痛み軽減の有効性試験を行い、次のような結
果を得た。Example 1 A gel composition having the above composition is uniformly spread on a non-woven fabric so as to have a thickness of 1.0 mm, applied, and naturally dried and then steam sterilized, and a skin-damaged surface protective material of the present invention, particularly dermatome skin We were able to obtain the optimal one for wound pain relief. The effectiveness test of the pain reduction was conducted and the following results were obtained.
(i)方法 使用対象としてデルマトームによる採皮創を選び、創の
深さ、広さ、部位、患者の年齢等について、効果比較用
の局方ガーゼ15枚重ねと本保護材両者に対し同一条件
に近くなるように選んだ。(I) Method Select a dermatome wound as a target for use, and regarding the depth, width, site, patient age, etc. of the wound, use the same conditions for both the 15 layers of gauze for comparison of efficacy and this protective material. I chose to be close to.
(ii)結果 貼付後、1、3、7日毎の疼痛の程度を比較した結果、
第1図に示すような結果を得た。aは本発明による保護
材を使用した場合、bは局方ガーゼ15枚重ねを使用し
た場合で、(イ)痛みがない、(ロ)痛みがある、
(ハ)激しい痛みがある、の3つの症例に分けた結果、
本発明による保護材を使用すると、1日が疼痛が著しく
軽減されることがわかる。(ii) Results As a result of comparing the degree of pain every 1, 3, and 7 days after application,
The results shown in FIG. 1 were obtained. a is the case where the protective material according to the present invention is used, b is the case where 15 gauze gauze layers are used, (a) no pain, (b) there is pain,
(C) As a result of dividing into 3 cases of severe pain,
It can be seen that the use of the protective material according to the invention significantly reduces the pain during the day.
実施例2 上記組成のゲル組成物を不織布上に厚さ2.0mmとなるよ
う均一に展延、塗布し、加熱乾燥後、蒸気滅菌して本発
明の皮膚損傷面保護材、特に赤色肉芽が形成され滲出液
の少なくなった開放創の治療促進材として最適なものを
得ることができた。その治療促進機能の有効性試験を行
い、次のような結果を得た。Example 2 The gel composition of the above composition is uniformly spread on a non-woven fabric so as to have a thickness of 2.0 mm, applied, dried by heating, and sterilized by steam to protect the skin-damaged surface of the present invention, in particular, red granulation is formed and exudate. We were able to obtain the most suitable material as a therapeutic accelerator for open wounds with reduced number of patients. The efficacy test of the treatment promoting function was conducted and the following results were obtained.
(i)方法 ラットの毛をはさみで刈り、皮膚表面を石鹸と水で洗浄
し、麻酔をかけ、デルマトームにて背部両側に厚さ25
/1000インチ、7×10mmの長方形の傷を10個ず
つつくった。一方の創を本発明の保護材で覆い、他方の
創を局方ガーゼ5枚重ねし、毎日上皮化された面積を測
定し、上皮化率(治療率)とした。(I) Method The hair of a rat is cut with scissors, the skin surface is washed with soap and water, anesthetized, and a thickness of 25 on both sides of the back with a dermatome.
/ 1000 inch, 7 × 10 mm rectangular scratches were made 10 each. One wound was covered with the protective material of the present invention, and the other wound was overlaid with five pieces of pharmacological gauze, and the area of epithelialization was measured every day to give the epithelialization rate (treatment rate).
(ii)結果 経過日数に対する上皮化率として第2図に示すような結
果を得た。aは本発明による保護材を使用した場合、b
はガーゼ5枚重ねの場合で、本発明の方が少ない日数で
高い上皮化率に達することがわかる。(ii) Results The results shown in Fig. 2 were obtained as the rate of epithelialization with respect to the elapsed days. a is the case where the protective material according to the present invention is used, b
In the case of 5 layers of gauze, it can be seen that the present invention achieves a high epithelialization rate in less days.
なお、上記実施例1、2の皮膚損傷面保護材を加熱乾燥
して水分を除いたもの、あるいは使用直前に生理食塩水
に1〜2分浸したものについても同様の試験を行い、同
様の効果を有することが認められた。The same test was carried out on the skin-damaged surface protecting materials of Examples 1 and 2 above, which were dried by heating to remove water, or those which were soaked in physiological saline for 1 to 2 minutes immediately before use. It was confirmed to have an effect.
第3図aは支持体に形成する切り込みのパターンの一例
で、直線上に不連続的に形成した切り込みを互いに平行
に並べ、かつ交互に切り込みのある位置をずらしてAの
列とBの列とから形成されている。第4図は支持体を切
り込みの長手方向に直角に切った断面で、支持体1の全
厚さdより小さい深さtを有する切り込み2が形成され
ていることがわかる。第3図aにおいて、例えばAの列
の切り込みのある位置に沿って切り込みの長手方向に直
角に矢印Pの方向に両側に引張ると、その位置の切り込
みは引き裂け、第4図の深さtは全厚さdに達し、第3
図bに示すように開孔されることになる。したがって、
引張る位置を選定することによって開孔位置、開孔数を
変えることができる。それ故、損傷面の滲出液の多少に
応じて切り込みの開孔状態を変えることによって、滲出
液を十分に透過させることができ、化膿の原因ともなる
滲出液の貯留を防止することができる。FIG. 3a is an example of a notch pattern formed on a support, in which discontinuous notches formed on a straight line are arranged in parallel to each other, and the positions of the notches are alternately shifted to row A and row B. It is formed from and. FIG. 4 is a cross-section of the support cut perpendicularly to the longitudinal direction of the cut, and it can be seen that a cut 2 having a depth t smaller than the total thickness d of the support 1 is formed. In Fig. 3a, for example, if a line is cut along the position of a notch in row A and is pulled to both sides in the direction of arrow P at right angles to the longitudinal direction of the notch, the notch at that position tears and the depth t in Fig. 4 becomes Reaches the total thickness d, the third
The holes will be opened as shown in FIG. Therefore,
By selecting the pulling position, it is possible to change the hole position and the number of holes. Therefore, by changing the open state of the cut depending on the amount of exudate on the damaged surface, the exudate can be sufficiently permeated and the accumulation of exudate, which causes suppuration, can be prevented.
切り込みの大きさは、第5図において 1mm≦a(a′)≦10mm 0.5mm≦b(b′)≦5mm 1mm≦c(c′)≦10mm 0mm≦ x ≦amm とするのが好ましい。なお切り込みのパターンは第3図
aに示すものに限らず、直線あるいは曲線を組合わせて
種々のものを使用することができる。The size of the cut is preferably 1 mm≤a (a ') ≤10 mm 0.5 mm≤b (b') ≤5 mm 1 mm≤c (c ') ≤10 mm 0 mm≤x≤a mm in FIG. The cut pattern is not limited to that shown in FIG. 3a, and various combinations of straight lines or curved lines can be used.
本発明によれば、皮膚損傷面に当てて使用した場合、多
価アルコール中でコロイド状懸濁液を形成する親水性高
分子と多価アルコールとを含有するゲル組成物は密着性
を有するため患部に良くなじみ、その上から軽くかぶせ
包帯等で補助的に固定するだけでよいから、粘着テープ
等によるかぶれなどを生じることがなく、また安全性の
高い成分を使用しているため損傷面はもちろんそれ以外
の部分にもかぶれなどが生ぜず、しかも透湿性が高いの
で患部がむれたり、むれが原因となるかぶれを引き起こ
すこともなく、更に柔軟性を有するため外部およびそれ
自体の物理的刺激がなく痛みを和らげ、支持体にはその
厚さ全体には達しない切り込みを設けてあるから、損傷
面から出る滲出液の量の多少に応じて適宜の数の切り込
みを引き裂いて開孔せしめ、滲出液を保護材外部に排出
させることにより、滲出液の停留による化膿の危険性も
防止できるなどの種々の優れた効果を有し、皮膚損傷面
の保護に極めて有効である。According to the present invention, a gel composition containing a polyhydric alcohol and a hydrophilic polymer that forms a colloidal suspension in a polyhydric alcohol has adhesiveness when used against a skin-damaged surface. It fits well on the affected area, and it is only necessary to lightly cover it over it with an auxiliary material such as a bandage to prevent it from getting rash due to adhesive tape, etc. Of course, no rashes occur in other parts, and since the moisture permeability is high, the affected area does not get swelled or rashes caused by swelling do not occur, and since it is more flexible, physical irritation of the outside and itself Since there is no notch, and the support is provided with notches that do not reach the entire thickness of the support, an appropriate number of notches are torn and opened depending on the amount of exudate emerging from the damaged surface. Allowed, by discharging the exudate protective material outside, it has various excellent effects such can be prevented danger of suppuration by retention of exudates, which is very effective in the protection of the skin-damaging.
第1図a、bは本発明による保護材と従来のものとの痛
み軽減効果の試験結果を示す線図,第2図は本発明によ
る保護材と従来のものとの治療効果の試験結果を示す線
図、第3図a、bは本発明に用いられる支持体に形成す
るパターンの一例のそれぞれ開孔前および開孔後の説明
図、第4図は本発明に用いられる支持体の一例の断面
図、第5図は支持体に形成するパターンの大きさの説明
図である。 1…支持体、2…切り込み。1a and 1b are diagrams showing the test results of the pain reducing effect of the protective material according to the present invention and the conventional one, and FIG. 2 shows the test results of the therapeutic effect of the protective material according to the present invention and the conventional one. 3A and 3B are explanatory diagrams of an example of a pattern formed on the support used in the present invention before and after opening, respectively, and FIG. 4 is an example of the support used in the present invention. FIG. 5 is an explanatory view of the size of the pattern formed on the support. 1 ... Support, 2 ... Notch.
Claims (1)
成する親水性高分子及び多価アルコールを含有するゲル
組成物を支持体に塗布し、この支持体にその厚さ全体に
は達しない切り込みを設け、この切り込みは引き裂くこ
とにより支持体外部に開孔し得るようになっていること
を特徴とする皮膚損傷面保護材。1. A gel composition containing a hydrophilic polymer that forms a colloidal suspension in a polyhydric alcohol and a polyhydric alcohol is applied to a support, and the support reaches the entire thickness thereof. A material for protecting a skin-damaged surface, wherein a notch is provided, and the notch can be torn to open a hole outside the support.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61124759A JPH0649065B2 (en) | 1986-05-30 | 1986-05-30 | Skin damage protection material |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61124759A JPH0649065B2 (en) | 1986-05-30 | 1986-05-30 | Skin damage protection material |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62281952A JPS62281952A (en) | 1987-12-07 |
| JPH0649065B2 true JPH0649065B2 (en) | 1994-06-29 |
Family
ID=14893411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61124759A Expired - Lifetime JPH0649065B2 (en) | 1986-05-30 | 1986-05-30 | Skin damage protection material |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0649065B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8818114D0 (en) * | 1988-07-29 | 1988-09-01 | Johnson & Johnson | Haemostatic wound dressing material |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5718629A (en) * | 1980-01-03 | 1982-01-30 | Key Pharma | Polymer diffused matrix |
| JPH062150B2 (en) * | 1983-09-12 | 1994-01-12 | リ−ドケミカル株式会社 | Base for patches |
-
1986
- 1986-05-30 JP JP61124759A patent/JPH0649065B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62281952A (en) | 1987-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7615236B1 (en) | Medical dressing for application and maintenance of medication on body tissue | |
| JP4213591B2 (en) | Pharmaceutical material for wound | |
| USRE42755E1 (en) | Honey based wound dressing | |
| DE69808275T2 (en) | ADHESIVE AND ITS USE | |
| KR102818950B1 (en) | Wound dressing | |
| US20080027365A1 (en) | Hemostatic device with oxidized cellulose pad | |
| US20070269499A1 (en) | Materials and methods for wound treatment | |
| US9962402B2 (en) | Healing composition for topical application | |
| JP2527132B2 (en) | Topical drug composition comprising hydrophilic polysaccharide | |
| JPS62275456A (en) | Wound protective material | |
| JP3550685B2 (en) | Wound healing agent | |
| DE60207606T2 (en) | ARTICLES OF WOUND TREATMENT | |
| Van Gils et al. | Improved healing with a collagen-alginate dressing in the chemical matricectomy | |
| JPH0649065B2 (en) | Skin damage protection material | |
| JP4187976B2 (en) | Adhesive bandage | |
| ES2312421T3 (en) | PHARMACEUTICAL COMPOSITION IN GEL. | |
| RU2205033C2 (en) | Curative material of prolonged action | |
| KR20190083593A (en) | Only for chronic wounds dressing and method of using it | |
| Mayorova et al. | Modern assortment, properties and perspectives of medical dressings improvement of wound treatment | |
| Shirah et al. | Effect of surgical wound care methods of the lay open technique on the outcome of chronic sacrococcygeal pilonidal sinus management | |
| DE202008000101U1 (en) | wound dressing | |
| US6780425B1 (en) | Method for application and maintenance of medication on body tissue | |
| EP0692254A1 (en) | Medicine for the topical treatment of skin | |
| US20240423844A1 (en) | Topical wound dressings and methods for use thereof | |
| CN102858350A (en) | Nail discoloration and fungus treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |